UVB Upregulates the Antimicrobial Protein hCAP18 mRNA in Human Skin  by Mallbris, Lotus et al.
See related Commentary on page xvi
UVB Upregulates the Antimicrobial Protein hCAP18 mRNA in
Human Skin
To the Editor:
Human antimicrobial protein (hCAP18), is an effector mol-
ecule of the innate immune system. Its C-terminal peptide
LL-37 has broad antibacterial activity in vitro, and current
research indicates that it is important in protecting the in-
tegrity of the skin. The in vivo importance of hCAP18/LL-37
in antimicrobial defense is supported by laboratory animal
models (Nizet et al, 2001). In addition to its antibiotic effects,
hCAP18 is emerging as a multifunctional protein involved
in chemotaxis, neo-angiogenesis (Koczulla et al, 2003), and
wound healing (Heilborn et al, 2003). hCAP18 is widely ex-
pressed in leukocytes and in epithelia, and is upregulated in
response to inflammation and injury in the skin (Dorschner
et al, 2001; Heilborn et al, 2003).
Molecular mechanisms regulating the expression of
hCAP18 in vivo are still poorly understood. We and others
have recently shown that vitamin D treatment rapidly and
directly upregulates the production of hCAP18 in human
keratinocytes in vitro through binding a functional vitamin D
responsive element (VDRE), in the hCAP18 gene promoter
(Wang et al, 2004; Weber et al, 2005). We have further ver-
ified the effect in human skin in vivo following topical ap-
plication of a vitamin D analog ointment, calcipotriol (Weber
et al, 2005). The aim of this study was to explore the physio-
logic relevance of this pharmacologic effect using UVB as
the natural stimulus for vitamin D production in human skin.
Here we demonstrate that irradiation with a single dose
of UVB but not of UVA significantly upregulated the expres-
sion of hCAP18 and vitamin D receptor (VDR) in the skin of
healthy volunteers. These findings indicate that vitamin D
may be a natural regulator for hCAP18 expression in the
skin.
The study was performed using a protocol for UVB irra-
diation that was previously shown to induce vitamin D in
human skin (Lehmann et al, 2003). Eight healthy Caucasian
individuals with no history of skin disease were recruited for
the study, which was approved by the Regional Committee
of Ethics and was conducted according to the Declaration
of Helsinki Principles. Written informed consent was given
by all individuals. Only fair-skinned individuals with skin
types II and III were selected in order to optimize the vitamin
D-inducing effect from UVB. The minimal erythema dose
(MED), in response to UVB irradiation was determined for all
individuals (Table I). MED is defined as the lowest UVB dose
evoking a minimal erythema 24 h after exposure. The UVB
source was an Osram Xenon arc lamp with a Schott 295 filter
(Carl Zeiss AB, Stockholm, Sweden) emitting 280–315 nm
with an intensity of 2.3 mW per cm2. The experiment
was performed as follows: a single MED dose of UVB was
delivered to untanned buttock skin of each individual. At
24–28 h following exposure, a 6 mm2 punch biopsy was
obtained from the irradiated area that displayed a barely
detectable erythema. A control biopsy was obtained from
non-irradiated skin, and the tissues were snap-frozen as
described (Weber et al, 2005). On the other buttock, a single
dose of UVA1 20J per cm2 was given as an additional con-
trol, and after 24–28 h, a punch biopsy was obtained from
the irradiated area as described above. The UVA1 source
was a UVASUN 3000 lamp (Mutzhas, Germany) emitting
340–400 nm with an intensity of 61mW per cm2. RNA was
extracted from the tissues, and hCAP18 mRNA was deter-
mined by Real-Time PCR as described (Weber et al, 2005).
All measurements were normalized to the expression of 18S
RNA, and are presented as arbitrary units (Table I). In ad-
dition, the expression of the VDR, was determined using a
commercially available kit (Assay on Demand, Applied Bio-
systems, Foster City, California). The results show that both
hCAP18 mRNA and VDR expression were significantly up-
regulated (signed rank test; p¼0.008 and 0.02, respective-
ly) after exposure to UVB (Table I), whereas there were no
significant differences between non-irradiated skin and skin
exposed to UVA (Table I). Moreover, there was a significant
correlation between the responses in hCAP18 and VDR
mRNA induced by UVB (Spearman rank correlation
p¼0.01). There was a substantial variation between indi-
viduals in the non-exposed skin for both hCAP18 and VDR
expression. But the upregulation was proportional to base-
line levels.
In conclusion, we show that irradiation with UVB ac-
cording to a protocol that was reported to induce the
synthesis of vitamin D in human skin (Lehmann et al,
2003) significantly upregulated the expression of VDR and
hCAP18. These results are in line with our recent data (We-
ber et al, 2005) and indicate that the upregulation of
hCAP18 mRNA is associated with UVB-induced production
of vitamin D. The upregulation of VDR after UVB irradiation
is in accordance with previous findings demonstrating that
vitamin D induces the expression of VDR in keratinocytes
(Solvsten et al, 1997). The regulation of VDR expression,
however, seems complex and it has been reported that UVB
transiently downregulates the expression of VDR in kera-
tinocytes in vitro up to 24 h following irradiation (Courtois
et al, 1998).
Abbreviations: hCAP18, human antimicrobial protein; VDR, vitamin
D receptor
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LETTERS TO THE EDITOR 1073125 : 5 NOVEMBER 2005
In humans, skin is the major source for vitamin D and
interestingly its production in response to UVB is conserved
through evolution. The role of UVB-induced vitamin D pro-
duction, which has been demonstrated in earlier life forms
such as plants and phytoplankton, is unclear. In view of the
data presented here, an important physiologic function for
vitamin D in regulating components of the innate immune
system is emerging.
Thus, taken together, these findings suggest the evolu-
tion of an intriguing biosystem wherein the skin interacts
with the environment to enhance its antimicrobial protection
and repair.
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Neonatal Ultraviolet Radiation Exposure Is Critical for Malignant
Melanoma Induction in Pigmented Tpras Transgenic Mice
To the Editor:
Malignant melanoma (MM) in humans develops within a
complex etiologic framework of genetic, host, and environ-
mental factors (Goldstein and Tucker, 2001). The strongest
environmental risk factor is sun exposure (Sulaimon et al,
2003). In the mouse, wild-type animals are resistant to MM
development even when exposed to repeated treatments
with ultraviolet radiation (UVR) (Gallagher et al, 1984). Chronic
UVR treatment regimens, however, have increased MM
penetrance by up to 26% in mice carrying various trans-
genes capable of inducing spontaneous MM development,
or melanocytic hyperplasia, e.g., Tyr-SV40Tag (Klein-Szanto
et al, 1994; Kelsall and Mintz, 1998), TPras (Broome Powell
et al, 1999) and Mt-Hgf/Sf (Noonan et al, 2000) mice. More
recently, Noonan et al (2001) showed that a single neonatal
dose of 9 kJ per m2 was far more effective than chronic
treatments at inducing MM in the Mt-Hgf/Sf transgenics.
Kannan et al (2003) used the neonatal UVR regimen on mice
with melanocyte-specific activation of Hras on a background
of either Ink4a or Arf nullizygosity. At 22 wk, Ink4a/:Tyr-Hras
and Arf/:Tyr-Hras animals developed spontaneous MM,
with an incidence of 35% and 53%, respectively (Chin et al,
1997). Importantly, neonatal UVR exposure resulted in a
marked increase in MM development only in the Arf/:Tyr-
Hras animals (penetrance rose to 88%) (Kannan et al, 2003),
implying that a defect in the p53 pathway may be necessary
for UVR-induced MM. Arf/:Tyr-Hras tumors were charac-
terized by Cdk6 amplification and Ink4a mutation, genetic
lesions that were never observed in non-UVR-induced MM.
Notably, these secondary mutations indicate that these UVR-
induced MMmay only arise on an activated Hras background
when both the p53 and pRb pathways are compromised.
It has previously been demonstrated that pigmented Tyr-
SV40Tag mice treated with repeated neonatal UVR doses
from days 3–10, show increased rates of MM compared to
untreated animals (Klein-Szanto et al, 1994; Kelsall and
Mintz, 1998). These mice did not, however, develop me-
lanomas over their limited lifespan when treated with a sin-
gle neonatal dose. All subsequent studies have used albino
mouse strains for neonatal UVR experiments.
Evidence suggests that the Ras pathway is pivotal for
MM development. The RAS family is comprised of NRAS,
HRAS, KRAS, which are all involved in the mitogen-activat-
ed protein kinase (MAPK) and phosphatidylinositol 3-kinase
(PI3K) signalling cascades (Busca et al, 2000). There is a
high frequency of BRAF and NRAS mutation in melanocytic
Abbreviations: MAPK, mitogen-activated protein kinase; MM,
malignant melanoma; PI3K, phosphatidylinositol 3-kinase; UVR,
ultraviolet radiation
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